>
CIGB     cyto17 Inteernational Meetings
Cuba USA Swi France SouthA
Visitors:

General Info
List of Oral presentations
The following Oral Presentations will be delivered at Viral Infectious Diseases 2017:
Speaker Title Institution Country
Gerardo E. Guillén, PhD. Pending Title Center for Genetic Engineering and Biotechnology, CIGB cuba
Beat H. Meier, Prof. Solid-state NMR studies on the Hepatitis B core protein Full Professor of Physical Chemistry Federal Institute of Technology in Zurich, Switzerland switzerland
Anja Bockmann, PhD Wheat germ cell-free expression of the Hepatitis B small surface antigen from the human and duck viruses Directeur de recherches, Institut de Biologie et Chimie des Protéines, Lyon, France France
Roger Legrand, PhD New approaches for understanding mechanisms of vaccine induced immunity Directeur du Département, Service Immunologie des Infections Virales et des Maladies Auto-immunes (IMVA), Paris, France France
Lázaro Gil González, PhD A tetravalent formulation of recombinant nucleocapsid-like particles from dengue viruses induces a functional cellular immune response in mice and monkeys Center for Genetic Engineering and Biotechnology, CIGB Cuba
Enrique Iglesias, Prof. Preliminary assessment of safety and immunogenicity of the vaccine candidate Teravac-HIV-1 in seropositive patients Center for Genetic Engineering and Biotechnology, CIGB Cuba
Anuja Mathew, Dr. Novel assays to identify dengue-specific B-cells Research Associate Professor, College of the Environment and Life Science, The University of Rhode Island

USA
Celia Fernández Ortega, PhD. A novel molecule targeting vimentin intermediate filaments for the treatment of HIV infection Head of HIV Therapy Research. Center for Genetic Engineering and Biotechnology, CIGB


Cuba
Michal J Toborek, PhD. HIV infection in the aging brain Department of Biochemistry and Molecular Biology, University of Miami School of Medicine

USA
Nesri Padayatchi, PhD. Turning the tide on HIV, but not on TB Deputy Director CAPRISA, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Nelson R. Mandela School of Medicine, Durban, South Africa

USA
. J. Victor Garcia , PhD. Recent advances in humanized mice for HIV research
Center for AIDS Research (CFAR), the Institute for Global Health & Infectious Diseases (IGHID), and the Division of Infectious Diseases in the Department of Medicine, University of North Carolina at Chapel Hill

USA
Immo Weichert, PhD. The unwell returning traveller - a perspective from an acute physician in the UK National Health Service The Ipswich Hospital NHS Trust, Heath Road, Ipswich, Suffolk, United Kingdom


UK
Lucyna Cova, PhD. Intrahepatic surface antigen clearance following therapy of chronic hepatitis B combining nucleic acid polymer REP 2139 and nucleos(t)ide analogues Group of Pathogenesis of hepatitis B and C infections,Cancer Research Center of Lyon, France


France
Marie-Louise Michel, PhD. The long road to animal models for HBV infection Laboratoire de Pathogenèse des virus de l’hépatite B Institut Pasteur and INSERM U994, Paris, France


France
Marie-Lise Gougeon, PhD. Innate Sensing of Viral Infections: the Janus Face of Dendritic Cells and their Contribution to HIV Reservoirs Director, Infection and Epidemiology Department. Director, Innate Immunity and Viruses, Unit Institut Pasteur


France
Drew Weissman, M.D, PhD. Nucleoside-modified mRNA immunization elicits potent T follicular helper cell responses Division of Infectious Diseases University of Pennsylvania


USA
Jorge Pérez , PhD.  HIV infection in Cuba. Results of ARV treatment 1986-2016 Institute for Tropical Medicine “Pedro Kouri


CUBA
María G. Guzmán, Prof. Emergency of arthropod transmitted viral Diseases. What to do? Director of Center for Research, Diagnosis and Reference.Institute for Tropical Medicine Pedro Kouri


Cuba
Iris Valdés, PhD. The Cuban dengue vaccine candidate based on recombinant domain III-capsid proteins Dengue Vaccine Group. Vaccine Department. CIGB


Cuba
Vivian Kouri, PhD. HIV-1 viral variants circulating in Cuba. Implications for disease progression Head of the Virology Department and STI Laboratory Virology Department, Center for Research, Diagnosis and Reference. Institute for Tropical Medicine “Pedro Kouri”


Cuba
Julio C Aguilar, PhD. Five year follow-up of chronic hepatitis B patients immunized by nasal route with the therapeutic vaccine HeberNasvac. Head of Hepatitis B Vaccine Group, Vaccine Department, CIGB


Cuba
Franco Pissani, PhD. FluoroSpot in vaccine research: multiplexing the sensitive ELISPOT assay Scientific Advisor, Marketing & Business Development Mabtech, Inc


USA
CIGB
Center for Genetic Engineering and Biotechnology, Havana, Cuba
address 31 Ave e/ 158 and 190, Cubanacan, Playa, Havana 10600, Cuba
phone (53-7) 250 4559
(53-7) 271 6022 7421 ext.1140
email biomed@cigb.edu.cu